daunorubicin has been researched along with naringenin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, H; Chen, FC; Flavin, MT; Hughes, SH; Lin, YM; Mata-Greenwood, E; Pai, YH; Pengsuparp, T; Pezzuto, JM; Schinazi, RF | 1 |
| Strassburg, CP; Tukey, RH | 1 |
| Martinka, P; Mirossay, L; Mojzis, J; Mojzisová, G; Sarisský, M | 1 |
| Afrin, R; Arumugam, S; Harima, M; Karuppagounder, V; Nakamura, M; Pitchaimani, V; Sreedhar, R; Suzuki, H; Suzuki, K; Thandavarayan, RA; Ueno, K; Watanabe, K | 1 |
1 review(s) available for daunorubicin and naringenin
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
3 other study(ies) available for daunorubicin and naringenin
| Article | Year |
|---|---|
In vitro anti-HIV activity of biflavonoids isolated from Rhus succedanea and Garcinia multiflora.
Topics: Anti-HIV Agents; Cell Survival; Cells, Cultured; Flavonoids; HIV Reverse Transcriptase; HIV-1; Humans; Lymphocytes; Plants, Medicinal; Plants, Toxic; Reverse Transcriptase Inhibitors; Toxicodendron; Virus Replication | 1997 |
Effect of flavonoids on daunorubicin-induced toxicity in H9c2 Cardiomyoblasts.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cells, Cultured; Chromans; Daunorubicin; Flavanones; Flavonoids; Myocytes, Cardiac; Plant Extracts; Quercetin; Rats | 2009 |
Naringenin ameliorates daunorubicin induced nephrotoxicity by mitigating AT1R, ERK1/2-NFκB p65 mediated inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibiotics, Antineoplastic; Apoptosis; Daunorubicin; Endoplasmic Reticulum Stress; Fibrosis; Flavanones; Inflammation; Injections, Intravenous; Kidney Diseases; Male; MAP Kinase Signaling System; PPAR gamma; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renal Agents; Transcription Factor RelA | 2015 |